Marshall Wace Portfolio holdings
AUM
$84.1B
This Quarter Return
+6.39%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$49.9B
AUM Growth
+$49.9B
(+148%)
Cap. Flow
+$29.4B
Cap. Flow
% of AUM
58.81%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
4,360
New
1,424
Increased
1,001
Reduced
555
Closed
657
Top Buys
| 1 |
Microsoft
MSFT
|
$1.12B |
| 2 |
Amazon
AMZN
|
$978M |
| 3 |
Apple
AAPL
|
$946M |
| 4 |
Meta Platforms (Facebook)
META
|
$855M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$729M |
Top Sells
| 1 |
Accenture
ACN
|
$218M |
| 2 |
West Pharmaceutical
WST
|
$116M |
| 3 |
Advanced Micro Devices
AMD
|
$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$89.3M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$80.1M |
Sector Composition
| 1 | Technology | 19.25% |
| 2 | Healthcare | 18.96% |
| 3 | Financials | 16.87% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Communication Services | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.77T
| $1.44B | 2.65% | 4,272,536 +3,319,846 | +348% | +$1.12B |
|
|
2
Amazon
AMZN
$2.44T
| $1.2B | 2.22% | 360,892 +293,406 | +435% | +$978M |
|
|
3
Apple
AAPL
$3.45T
| $1.16B | 2.14% | 6,541,140 +5,326,132 | +438% | +$946M |
|
|
4
Meta Platforms (Facebook)
META
$1.86T
| $884M | 1.63% | 2,627,404 +2,542,775 | +3,005% | +$855M |
|
|
5
Alphabet (Google) Class A
GOOGL
$2.57T
| $822M | 1.52% | 283,760 +251,525 | +780% | +$729M |
|
6
Thermo Fisher Scientific
TMO
$186B
| $696M | 1.29% | 1,043,844 +640,091 | +159% | +$427M |
|
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $665M | 1.23% | 229,779 +204,394 | +805% | +$591M |
|
8
SPDR S&P 500 ETF Trust
SPY
$659B
| $542M | 1% | +1,140,732 | New | +$542M |
|
9
NVIDIA
NVDA
$4.25T
| $510M | 0.94% | 1,733,857 +1,581,200 | +1,036% | +$465M |
|
10
Micron Technology
MU
$133B
| $507M | 0.94% | 5,446,043 +4,897,035 | +892% | +$456M |
|
11
UnitedHealth
UNH
$281B
| $433M | 0.8% | 861,798 +829,614 | +2,578% | +$417M |
|
12
Johnson & Johnson
JNJ
$427B
| $415M | 0.77% | 2,426,151 +1,981,275 | +445% | +$339M |
|
13
S&P Global
SPGI
$167B
| $414M | 0.76% | 876,875 +700,082 | +396% | +$330M |
|
14
Goldman Sachs
GS
$226B
| $394M | 0.73% | 1,031,239 +972,676 | +1,661% | +$372M |
|
15
Linde
LIN
$224B
| $387M | 0.71% | 1,115,691 +955,525 | +597% | +$331M |
|
|
BHVN
16
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $386M | 0.71% | 2,798,457 +80,272 | +3% | +$11.1M |
|
17
Comcast
CMCSA
$125B
| $381M | 0.7% | 7,571,121 +6,812,876 | +899% | +$343M |
|
18
Interactive Brokers
IBKR
$27.7B
| $346M | 0.64% | 4,359,441 +2,625,600 | +151% | +$209M |
|
19
Alibaba
BABA
$322B
| $316M | 0.58% | +2,662,000 | New | +$316M |
|
20
Pfizer
PFE
$141B
| $315M | 0.58% | 5,327,731 +3,778,140 | +244% | +$223M |
|
21
Bio-Techne
TECH
$8.5B
| $300M | 0.55% | 580,835 +350,215 | +152% | +$181M |
|
22
Darling Ingredients
DAR
$5.37B
| $286M | 0.53% | 4,126,968 +3,822,875 | +1,257% | +$265M |
|
23
Broadcom
AVGO
$1.4T
| $284M | 0.52% | 427,005 +377,418 | +761% | +$251M |
|
24
TransUnion
TRU
$17.2B
| $284M | 0.52% | 2,392,948 +1,654,197 | +224% | +$196M |
|
25
Zoetis
ZTS
$69.3B
| $279M | 0.52% | 1,142,793 +541,656 | +90% | +$132M |
|